Stada Arzneimittel AG - Company Profile
Powered by 
All the sales intelligence you need on Stada Arzneimittel AG in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Stada Arzneimittel AG fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Stada Arzneimittel AG.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Related keylists
Stada Arzneimittel AG (Stada), a subsidiary of Nidda Healthcare GmbH, develops and markets consumer healthcare, generics, and specialty pharmaceutical products. The company’s operational network, business performance of the generic segment, and wide product portfolio are its major strengths, even as private ownership is a cause of concern. The company could find growth opportunities through strategic acquisitions and asset purchase, regulatory approvals, and a positive outlook for the global pharmaceutical market. However, intense competition, growing parallel trade, and increased scrutiny of pharmaceutical ingredients may adversely affect its performance.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer